Literature DB >> 8826936

Hereditary nonpolyposis colorectal cancer (Lynch syndrome). An updated review.

H T Lynch1, T Smyrk.   

Abstract

BACKGROUND: Hereditary nonpolyposis colorectal cancer (HNPCC) dates to Aldred Warthin's description of Family G a century ago. The phenotype features an excess of early onset colorectal carcinoma (CRC) with a propensity to involve the proximal colon, and a variety of extracolonic cancers, particularly carcinoma of the endometrium, ovary, stomach, small bowel, ureter, and renal pelvis. The recent discovery that HNPCC patients carry germline mutations in DNA mismatch repair genes has engendered great interest in the syndrome.
METHODS: This is a description of HNPCC based on the authors' experience with more than 170 families and a review of the world literature.
RESULTS: This review describes the genotypic and phenotypic features of HNPCC. The distinctive natural history of the syndrome is discussed in light of the recent discovery that ineffective DNA mismatch repair is the principal abnormality in affected individuals.
CONCLUSIONS: Clinical and molecular genetic knowledge about HNPCC is now available to physicians, and should enable them to provide highly targeted surveillance and management for patients with a high cancer risk. Genetic counseling can prove lifesaving. The study of HNPCC will likely contribute to knowledge about the causes and control of common forms of cancer in the general population.

Entities:  

Mesh:

Year:  1996        PMID: 8826936     DOI: 10.1002/(SICI)1097-0142(19960915)78:6<1149::AID-CNCR1>3.0.CO;2-5

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  104 in total

Review 1.  DNA mismatch repair genes and colorectal cancer.

Authors:  J M Wheeler; W F Bodmer; N J Mortensen
Journal:  Gut       Date:  2000-07       Impact factor: 23.059

2.  Evaluation of a counselling protocol for predictive genetic testing for hereditary non-polyposis colorectal cancer.

Authors:  K Aktan-Collan; J P Mecklin; A de la Chapelle; P Peltomäki; A Uutela; H Kääriäinen
Journal:  J Med Genet       Date:  2000-02       Impact factor: 6.318

3.  MED1, a novel human methyl-CpG-binding endonuclease, interacts with DNA mismatch repair protein MLH1.

Authors:  A Bellacosa; L Cicchillitti; F Schepis; A Riccio; A T Yeung; Y Matsumoto; E A Golemis; M Genuardi; G Neri
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

Review 4.  [Evaluation of cancer risk through genetic analysis?].

Authors:  A Luz
Journal:  Strahlenther Onkol       Date:  1997-09       Impact factor: 3.621

5.  Green tea polyphenol epigallocatechin 3-gallate, contributes to the degradation of DNMT3A and HDAC3 in HCT 116 human colon cancer cells.

Authors:  Vondina R Moseley; Jay Morris; Rebecca W Knackstedt; Michael J Wargovich
Journal:  Anticancer Res       Date:  2013-12       Impact factor: 2.480

6.  Clinical characteristics and diagnosis of patients with hereditary nonpolyposis colorectal cancer.

Authors:  San-Jun Cai; Ye Xu; Guo-Xiang Cai; Peng Lian; Zu-Qing Guan; Shan-Jing Mo; Meng-Hong Sun; Qi Cai; Da-Ren Shi
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

7.  Colorectal cancer: epidemiology, risk factors, and health services.

Authors:  Farin Amersi; Michelle Agustin; Clifford Y Ko
Journal:  Clin Colon Rectal Surg       Date:  2005-08

8.  Mismatch repair protein expression and colorectal cancer in Hispanics from Puerto Rico.

Authors:  Wilfredo E De Jesus-Monge; Carmen Gonzalez-Keelan; Ronghua Zhao; Stanley R Hamilton; Miguel Rodriguez-Bigas; Marcia Cruz-Correa
Journal:  Fam Cancer       Date:  2010-06       Impact factor: 2.375

9.  Frequency of replication errors in colorectal cancer and their association with family history.

Authors:  S R Brown; P J Finan; L Cawkwell; P Quirke; D T Bishop
Journal:  Gut       Date:  1998-10       Impact factor: 23.059

10.  Are relatives of patients with multiple HNPCC spectrum tumours at increased risk of cancer?

Authors:  S R Brown; P J Finan; D T Bishop
Journal:  Gut       Date:  1998-11       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.